Ogawa Osamu, MD, PhD, Professor
We engaged in various approaches such as cancer treatment, transplantation therapy and development of new medical treatment. Especially we are focusing on cancer treatment. We have started endoscopic surgery for more than 30 years, and we are recently aiming to reduce invasion and improve prognosis by a state-of-the-art surgical robot. Development of various new drugs and medical instruments have increased the options of therapy, but the choice has become complicated.
Our team have experienced staff in cancer treatment, and we can provide advanced medical care with quality of life.
Research and Education80 years have passed since the establishment of the Kyoto University Urology Department. We have focused on urologic oncology and minimally invasive endoscopic surgery. Molecular genetics research on urological tumors has always been the cutting edge of the world. Laparoscopic surgery on urological tumors, which began 30 years ago, continues to affect urologic surgery in Japan.
Medical school of university have three missions: research, medical treatment and education. Education is most important thing we consider to support the cutting-edge research and advanced medical care. The policy is” Training professional urologists”. We have been conducting the specialist education program “Kyoto University Wide-area Collaboration Specialist Training Program” after the reform of the Specialist doctor training system in 2018. However we have already started the program since 2004. In cooperation with 30 related facilities, about 80 urologists have already been trained along this program. We believe that high quality research and medical treatment can be performed if we prepare training environment that is best for young urologists who will lead the future.
Experiment using urological cancer cell lines
Basic research using clinical materials
- Sumiyoshi T, Mizuno K, Yamasaki T, et al. Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer. Sci Rep. 2019 Mar 11;9(1):4030. doi: 10.1038/s41598-019-40719-y.
- Sengiku A, Ueda M, Kono J, et al. Circadian coordination of ATP release in the urothelium via connexin43 hemichannels. Sci Rep. 2018 Jan 31;8(1):1996. doi: 10.1038/s41598-018-20379-0.
- Sakamoto H, Yamasaki T, Sumiyoshi T, et al. A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis. J Clin Pathol. 2018 Oct;71(10):936-943. doi: 10.1136/jclinpath-2018-205211. Epub 2018 Jun 30.
- Masuda N, Ogawa O, Park M, et al. Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer. Oncotarget. 2018 Jan 3;9(6):7101-7111. doi: 10.18632/oncotarget.23872. eCollection 2018 Jan 23.
- Okada Y, Sonoshita M, Kakizaki F, et al. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.
UrologyProfessor: Osamu Ogawa
Associate Professor: Takahiro Inoue
Senior Lecturer: Toshinari Yamasaki・Takashi Kobayashi
Assistant Professor: Ryoichi Saito・Shusuke Akamatsu・Atsuro Sawada・Takayuki Goto・Yuki Kita・Takayuki Yoshino